(Reuters) - U.S. drugmaker AbbVie Inc said on Monday it has reached agreement with Shire Plc to officially call off its proposed $55 billion (34.03 billion pounds) purchase of the Irish company, and will pay Shire a $1.64 billion breakup fee for walking away from the deal.